TY  - GEN
AU  - You,Abin
AU  - Cao,Manqing
AU  - Guo,Zhigui
AU  - Zuo,Bingfeng
AU  - Gao,Junrong
AU  - Zhou,Hongyuan
AU  - Li,Huikai
AU  - Cui,Yunlong
AU  - Fang,Feng
AU  - Zhang,Wei
AU  - Song,Tianqiang
AU  - Li,Qiang
AU  - Zhu,Xiaolin
AU  - Yin,Haifang
AU  - Sun,Huichuan
AU  - Zhang,Ti
TI  - Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
SN  - 1756-8722
PY  - 2016///1024
KW  - Acetyltransferases
KW  - metabolism
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Basic Helix-Loop-Helix Transcription Factors
KW  - Blotting, Western
KW  - Carcinoma, Hepatocellular
KW  - drug therapy
KW  - Cell Hypoxia
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Cell Survival
KW  - Drug Synergism
KW  - Epithelial-Mesenchymal Transition
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Liver Neoplasms
KW  - Male
KW  - Metformin
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Niacinamide
KW  - Phenylurea Compounds
KW  - Sorafenib
KW  - Transcription Factors
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/s13045-016-0253-6
ER  -